Convergent Dental's CEO to Present for Third Consecutive Year on Laser Dentistry Innovation
WALTHAM, Mass., Nov. 15, 2024 /PRNewswire-PRWeb/ -- Convergent Dental, the power behind the Solea® All-Tissue Dental Laser, announced today its participation in the Piper Sandler 36th Annual Healthcare Conference, taking place December 3-5, 2024, at The Lotte New York Palace in New York, NY. This invitation-only event gathers key healthcare executives, investors, and industry experts to explore critical trends and identify the leaders driving the healthcare sector forward.
Rob Gershon, CEO of Convergent Dental, will present on Thursday, December 5, at 8:50 a.m. EST. In addition to his presentation, Convergent Dental will hold one-on-one meetings that same day with investors and industry professionals, providing insight into Convergent Dental's latest advancements and vision for driving the broad-based adoption of Solea.
About Convergent Dental
Convergent Dental, Inc. () is a privately owned dental equipment and technology company. The Company's flagship product, Solea®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers an anesthesia-free, blood-free, suture-free experience that dentists and patients can rely on.[1] Solea® enables dentists to elevate their practices through improved efficiency, patient experience, clinical effectiveness, and procedural expansion.[2]
1. Based on report of 1000 procedures performed by Solea users. Documentation on file.
2. Based on 2022 Annual Survey of Solea users. Documentation on file.
Media Contact
Caitlin D'Entremont, Convergent Dental, 1 5085005656, [email protected],
,
SOURCE Convergent Dental
Share this article